Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/2316

TDMS Study 05067-09 Pathology Tables

NTP Experiment-Test: 05067-09         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            THEOPHYLLINE                                       Date: 07/11/96
Route: GAVAGE                                                                                                     Time: 16:17:04

                                                           CORE STUDY




       Facility:  Southern Research Institute

       Chemical CAS #:  58-55-9

       Lock Date:  09/03/93

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All


































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1

NTP Experiment-Test: 05067-09         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            THEOPHYLLINE                                       Date: 07/11/96  
Route: GAVAGE                                                                                                     Time: 16:17:04  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   VEHICLE      7.5          25 MG/KG     75 MG/KG                                  
                                                   CONTROL      MG/KG                                                               
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                17           12           14            7                                     
    Natural Death                                      1            7            3            7                                     
    Dosing Accident                                                 1                         3                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                31           30           33           33                                     
    Natural Death                                      1                                                                            
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (50)         (50)         (50)         (50)                                   
      Inflammation, Focal                                           1 (2%)                                                          
      Perforation                                                   1 (2%)                                                          
   Intestine Large, Colon                             (50)         (47)         (50)         (50)                                   
      Parasite Metazoan                                                          4 (8%)       2 (4%)                                
   Intestine Large, Rectum                            (50)         (47)         (50)         (50)                                   
      Parasite Metazoan                                1 (2%)                    4 (8%)       2 (4%)                                
   Intestine Large, Cecum                             (50)         (47)         (50)         (50)                                   
      Parasite Metazoan                                                                       1 (2%)                                
   Liver                                              (50)         (50)         (50)         (50)                                   
      Angiectasis                                      1 (2%)                    2 (4%)       1 (2%)                                
      Basophilic Focus                                40 (80%)     37 (74%)     31 (62%)     32 (64%)                               
      Clear Cell Focus                                 3 (6%)                                 2 (4%)                                
      Eosinophilic Focus                               2 (4%)                                                                       
      Hemorrhage                                       1 (2%)                                                                       
      Hepatodiaphragmatic Nodule                       5 (10%)      4 (8%)       7 (14%)      7 (14%)                               
      Hyperplasia, Focal, Histiocytic                  6 (12%)      2 (4%)       1 (2%)       3 (6%)                                
      Hyperplasia, Focal, Lymphoid                     4 (8%)       2 (4%)       1 (2%)       4 (8%)                                
      Infiltration Cellular, Mixed Cell                1 (2%)                    5 (10%)      4 (8%)                                
      Mineralization, Focal                                                      1 (2%)                                             
      Mixed Cell Focus                                 2 (4%)       5 (10%)      5 (10%)      7 (14%)                               
      Vacuolization Cytoplasmic                        4 (8%)                                                                       
      Bile Duct, Hyperplasia                           8 (16%)      7 (14%)      4 (8%)       7 (14%)                               
      Centrilobular, Degeneration                                                1 (2%)                                             
      Centrilobular, Necrosis                          1 (2%)                                                                       
   Mesentery                                          (11)         (12)         (8)          (4)                                    
      Accessory Spleen                                 1 (9%)       1 (8%)                    1 (25%)                               
      Hemorrhage                                                                              1 (25%)                               
      Infiltration Cellular, Focal, Mixed Cell         1 (9%)                                                                       
      Inflammation, Chronic                            1 (9%)                                                                       
      Necrosis, Fatty                                               1 (8%)                                                          
      Artery, Inflammation, Chronic                    1 (9%)                    2 (25%)                                            
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 05067-09         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            THEOPHYLLINE                                       Date: 07/11/96  
Route: GAVAGE                                                                                                     Time: 16:17:04  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   VEHICLE      7.5          25 MG/KG     75 MG/KG                                  
                                                   CONTROL      MG/KG                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Fat, Necrosis                                    6 (55%)      9 (75%)      2 (25%)                                            
      Vein, Inflammation, Chronic                                                1 (13%)                                            
   Pancreas                                           (50)         (48)         (49)         (50)                                   
      Inflammation, Chronic                                                                   1 (2%)                                
      Acinus, Atrophy, Focal                           3 (6%)       9 (19%)     10 (20%)      9 (18%)                               
      Acinus, Hyperplasia, Focal                                    2 (4%)       1 (2%)                                             
   Salivary Glands                                    (50)         (49)         (50)         (50)                                   
      Duct, Cyst                                                                 1 (2%)                                             
   Stomach, Forestomach                               (50)         (50)         (50)         (50)                                   
      Inflammation, Chronic                            3 (6%)       1 (2%)                                                          
      Ulcer                                            1 (2%)                                                                       
      Epithelium, Hyperplasia                          2 (4%)                    1 (2%)                                             
   Tooth                                                           (1)                                                              
      Developmental Malformation                                    1 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (50)         (50)         (50)                                   
      Thrombosis                                       1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (50)         (50)         (50)                                   
      Accessory Adrenal Cortical Nodule                1 (2%)       3 (6%)                    2 (4%)                                
      Angiectasis                                      1 (2%)                                                                       
      Cytoplasmic Alteration, Focal                    6 (12%)      2 (4%)       6 (12%)      5 (10%)                               
      Hematopoietic Cell Proliferation                                           1 (2%)                                             
      Hemorrhage                                       1 (2%)                                 1 (2%)                                
      Vacuolization Cytoplasmic                                                               1 (2%)                                
   Adrenal Medulla                                    (50)         (49)         (50)         (49)                                   
      Hyperplasia                                      3 (6%)       4 (8%)       3 (6%)       5 (10%)                               
   Pituitary Gland                                    (47)         (50)         (49)         (49)                                   
      Angiectasis                                      6 (13%)      5 (10%)      6 (12%)      2 (4%)                                
      Fibrosis, Focal                                                                         1 (2%)                                
      Metaplasia, Focal, Osseous                                    1 (2%)                                                          
      Pars Distalis, Angiectasis                       1 (2%)                                 3 (6%)                                
      Pars Distalis, Cyst                              8 (17%)     14 (28%)      7 (14%)      7 (14%)                               
      Pars Distalis, Cytoplasmic Alteration, Focal     2 (4%)       4 (8%)       2 (4%)       4 (8%)                                
      Pars Distalis, Hyperplasia                                    1 (2%)                                                          
      Pars Distalis, Hyperplasia, Focal                3 (6%)       1 (2%)       2 (4%)       3 (6%)                                
      Pars Distalis, Necrosis                                                                 1 (2%)                                
   Thyroid Gland                                      (50)         (50)         (50)         (50)                                   
      Ultimobranchial Cyst                                                       1 (2%)                                             
      C-Cell, Hyperplasia                              6 (12%)      3 (6%)       1 (2%)       5 (10%)                               
      Follicle, Cyst                                   1 (2%)       1 (2%)       1 (2%)       2 (4%)                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 05067-09         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            THEOPHYLLINE                                       Date: 07/11/96  
Route: GAVAGE                                                                                                     Time: 16:17:04  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   VEHICLE      7.5          25 MG/KG     75 MG/KG                                  
                                                   CONTROL      MG/KG                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Follicular Cell, Hyperplasia                                               2 (4%)       1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (49)         (50)         (50)         (50)                                   
      Degeneration, Cystic                             8 (16%)      6 (12%)      8 (16%)      3 (6%)                                
      Hyperplasia                                      3 (6%)       1 (2%)       3 (6%)       2 (4%)                                
      Inflammation, Chronic                            2 (4%)                    2 (4%)       2 (4%)                                
   Ovary                                              (50)         (50)         (50)         (50)                                   
      Cyst                                             3 (6%)       2 (4%)       1 (2%)       2 (4%)                                
      Bilateral, Cyst                                               1 (2%)       1 (2%)                                             
   Uterus                                             (50)         (50)         (50)         (50)                                   
      Hemorrhage                                                    1 (2%)                                                          
      Hydrometra                                       1 (2%)       3 (6%)       2 (4%)       3 (6%)                                
      Hyperplasia, Cystic                              1 (2%)                                                                       
      Cervix, Hypertrophy                                                                     2 (4%)                                
      Endometrium, Hyperplasia, Cystic                 8 (16%)      7 (14%)      8 (16%)     11 (22%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (49)         (50)         (50)                                   
      Depletion Cellular                               1 (2%)       1 (2%)                                                          
      Hyperplasia                                                   1 (2%)                                                          
      Hyperplasia, Focal, Histiocytic                                            1 (2%)       4 (8%)                                
      Myelofibrosis                                                 1 (2%)       1 (2%)                                             
   Lymph Node                                         (9)          (10)         (9)          (8)                                    
      Iliac, Ectasia                                   1 (11%)                                                                      
      Inguinal, Pigmentation                                        1 (10%)                                                         
      Mediastinal, Ectasia                             1 (11%)                                                                      
      Mediastinal, Hemorrhage                                                    1 (11%)      2 (25%)                               
      Mediastinal, Pigmentation                        4 (44%)      3 (30%)      1 (11%)      2 (25%)                               
      Pancreatic, Ectasia                                                        1 (11%)                                            
      Pancreatic, Pigmentation                                                   1 (11%)                                            
      Renal, Hyperplasia                                            1 (10%)                                                         
   Lymph Node, Mandibular                             (49)         (48)         (50)         (50)                                   
      Congestion                                                                              2 (4%)                                
      Ectasia                                                                    1 (2%)       1 (2%)                                
      Hemorrhage                                                                 3 (6%)                                             
      Hyperplasia                                      1 (2%)                                                                       
      Hyperplasia, Lymphoid                                                      2 (4%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 05067-09         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            THEOPHYLLINE                                       Date: 07/11/96  
Route: GAVAGE                                                                                                     Time: 16:17:04  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   VEHICLE      7.5          25 MG/KG     75 MG/KG                                  
                                                   CONTROL      MG/KG                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
   Lymph Node, Mesenteric                             (50)         (50)         (50)         (50)                                   
      Hemorrhage                                                                 1 (2%)                                             
      Hyperplasia, Lymphoid                                                      1 (2%)                                             
      Pigmentation                                                  2 (4%)       1 (2%)       1 (2%)                                
   Spleen                                             (50)         (48)         (50)         (50)                                   
      Hematopoietic Cell Proliferation                 5 (10%)      7 (15%)     11 (22%)      3 (6%)                                
      Hemorrhage                                                                              1 (2%)                                
      Pigmentation                                                               2 (4%)                                             
   Thymus                                             (49)         (49)         (48)         (50)                                   
      Angiectasis                                                                             1 (2%)                                
      Cyst                                             1 (2%)       1 (2%)                    2 (4%)                                
      Hemorrhage                                                                              1 (2%)                                
      Hyperplasia, Lymphoid                                                                   1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (50)         (50)         (50)         (49)                                   
      Cyst                                             1 (2%)                                                                       
      Ectasia                                         26 (52%)     23 (46%)     23 (46%)     20 (41%)                               
      Hyperplasia                                      5 (10%)      3 (6%)       4 (8%)       6 (12%)                               
   Skin                                               (50)         (50)         (50)         (50)                                   
      Inflammation, Chronic, Focal                     2 (4%)       1 (2%)       2 (4%)                                             
      Ulcer                                            1 (2%)       3 (6%)       1 (2%)                                             
      Subcutaneous Tissue, Fibrosis, Focal             1 (2%)                                                                       
      Subcutaneous Tissue, Hemorrhage, Focal           1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (50)         (50)                                   
      Hyperostosis                                     5 (10%)      3 (6%)       2 (4%)       2 (4%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)         (50)                                   
      Atrophy, Focal                                  10 (20%)      7 (14%)      7 (14%)      8 (16%)                               
      Hemorrhage, Focal                                3 (6%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (50)         (50)                                   
      Congestion                                                    2 (4%)       1 (2%)       5 (10%)                               
      Hemorrhage                                                    1 (2%)       1 (2%)                                             
      Hyperplasia, Histiocytic                                                   1 (2%)       1 (2%)                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 05067-09         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            THEOPHYLLINE                                       Date: 07/11/96  
Route: GAVAGE                                                                                                     Time: 16:17:04  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   VEHICLE      7.5          25 MG/KG     75 MG/KG                                  
                                                   CONTROL      MG/KG                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
      Inflammation, Chronic                                         1 (2%)                                                          
      Alveolar Epithelium, Hyperplasia                 1 (2%)       1 (2%)       1 (2%)       3 (6%)                                
      Interstitium, Edema                                                        1 (2%)                                             
   Nose                                               (50)         (50)         (50)         (50)                                   
      Foreign Body                                     1 (2%)                                                                       
      Inflammation, Suppurative                        3 (6%)       3 (6%)       1 (2%)       2 (4%)                                
      Mucosa, Glands, Dilatation, Focal                             1 (2%)                                                          
      Nasolacrimal Duct, Inflammation, Suppurative     1 (2%)       1 (2%)                    1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (2)          (3)          (9)          (11)                                   
      Cataract                                                                                2 (18%)                               
      Inflammation, Chronic                                                                   1 (9%)                                
      Cornea, Inflammation, Chronic                                                           2 (18%)                               
      Cornea, Pigmentation                                                                    1 (9%)                                
      Retina, Degeneration                                                                    1 (9%)                                
      Sclera, Metaplasia, Focal, Osseous                            1 (33%)      3 (33%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (48)         (50)         (49)                                   
      Angiectasis                                                                             1 (2%)                                
      Cyst                                                          1 (2%)       2 (4%)                                             
      Fibrosis, Focal                                                                         1 (2%)                                
      Inflammation, Chronic                                                      1 (2%)                                             
      Inflammation, Suppurative                                                               1 (2%)                                
      Nephropathy                                     43 (86%)     36 (75%)     41 (82%)     41 (84%)                               
      Papilla, Mineralization, Focal                                1 (2%)                                                          
      Pelvis, Dilatation                                            1 (2%)                                                          
      Pelvis, Mineralization                                                     2 (4%)                                             
      Pelvis, Transitional Epithelium, Hyperplasia     1 (2%)       1 (2%)       2 (4%)                                             
      Renal Tubule, Pigmentation                                    1 (2%)                                                          
   Ureter                                             (1)                                                                           
      Inflammation, Chronic                            1 (100%)                                                                     
      Transitional Epithelium, Hyperplasia             1 (100%)                                                                     
   Urinary Bladder                                    (50)         (49)         (50)         (50)                                   
      Calculus Gross Observation                       1 (2%)                    1 (2%)                                             
      Calculus Micro Observation Only                  1 (2%)                                                                       
      Inflammation, Chronic                            1 (2%)                                                                       
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 05067-09         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            THEOPHYLLINE                                       Date: 07/11/96  
Route: GAVAGE                                                                                                     Time: 16:17:04  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   VEHICLE      7.5          25 MG/KG     75 MG/KG                                  
                                                   CONTROL      MG/KG                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
      Transitional Epithelium, Hyperplasia             1 (2%)                    1 (2%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 05067-09         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            THEOPHYLLINE                                       Date: 07/11/96  
Route: GAVAGE                                                                                                     Time: 16:17:04  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     VEHICLE      7.5          25 MG/KG     75 MG/KG                                  
                                                   CONTROL      MG/KG                                                               
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                21           11           18           13                                     
    Natural Death                                      5            5            2           13                                     
    Dosing Accident                                    1            1            1                                                  
  Survivors                                                                                                                         
    Terminal Sacrifice                                23           33           29           24                                     
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (50)         (50)         (50)         (50)                                   
      Hemorrhage                                                    1 (2%)                                                          
      Inflammation, Focal                                           1 (2%)       1 (2%)                                             
      Perforation                                      1 (2%)                    1 (2%)                                             
      Periesophageal Tissue, Inflammation, Focal       1 (2%)                                                                       
   Intestine Large, Rectum                            (49)         (48)         (50)         (49)                                   
      Parasite Metazoan                                             1 (2%)                                                          
   Liver                                              (50)         (50)         (50)         (50)                                   
      Angiectasis                                      1 (2%)       1 (2%)       1 (2%)                                             
      Basophilic Focus                                25 (50%)     20 (40%)     26 (52%)     14 (28%)                               
      Clear Cell Focus                                 4 (8%)       2 (4%)       1 (2%)       1 (2%)                                
      Congestion                                       1 (2%)                    2 (4%)       1 (2%)                                
      Degeneration, Cystic                             2 (4%)                                                                       
      Hemorrhage                                                                              1 (2%)                                
      Hepatodiaphragmatic Nodule                       6 (12%)      2 (4%)       3 (6%)       4 (8%)                                
      Hyperplasia, Focal, Histiocytic                                            1 (2%)                                             
      Infiltration Cellular, Mixed Cell                4 (8%)       3 (6%)       1 (2%)       1 (2%)                                
      Mineralization, Focal                                         1 (2%)                    1 (2%)                                
      Mixed Cell Focus                                 3 (6%)       3 (6%)       7 (14%)      3 (6%)                                
      Necrosis, Focal                                                                         2 (4%)                                
      Vacuolization Cytoplasmic                        2 (4%)                    1 (2%)                                             
      Bile Duct, Hyperplasia                          39 (78%)     39 (78%)     31 (62%)     29 (58%)                               
   Mesentery                                          (16)         (16)         (17)         (27)                                   
      Accessory Spleen                                                           1 (6%)                                             
      Artery, Inflammation, Chronic                    2 (13%)      2 (13%)      3 (18%)     15 (56%)                               
      Fat, Necrosis                                   15 (94%)     12 (75%)     15 (88%)     15 (56%)                               
      Lymphatic, Angiectasis                                                                  1 (4%)                                
   Pancreas                                           (50)         (50)         (50)         (50)                                   
      Acinus, Atrophy, Focal                          19 (38%)     13 (26%)     12 (24%)      9 (18%)                               
      Acinus, Hyperplasia                              1 (2%)                                                                       
      Acinus, Hyperplasia, Focal                       9 (18%)      5 (10%)      2 (4%)                                             
   Stomach, Forestomach                               (50)         (50)         (50)         (50)                                   
      Diverticulum                                     1 (2%)                                                                       
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
NTP Experiment-Test: 05067-09         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            THEOPHYLLINE                                       Date: 07/11/96  
Route: GAVAGE                                                                                                     Time: 16:17:04  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     VEHICLE      7.5          25 MG/KG     75 MG/KG                                  
                                                   CONTROL      MG/KG                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Edema                                                                      1 (2%)                                             
      Erosion                                          1 (2%)                                                                       
      Inflammation, Chronic                            5 (10%)                                3 (6%)                                
      Ulcer                                            2 (4%)                                                                       
      Epithelium, Hyperplasia                          6 (12%)                                3 (6%)                                
   Stomach, Glandular                                 (50)         (49)         (50)         (50)                                   
      Erosion                                          1 (2%)                                                                       
      Inflammation, Chronic                            2 (4%)                                                                       
      Mineralization                                                1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (50)         (50)         (50)                                   
      Fibrosis, Focal                                                                         1 (2%)                                
      Hypertrophy                                                   1 (2%)                                                          
      Inflammation, Chronic, Focal                                               1 (2%)                                             
      Mineralization                                                1 (2%)                    1 (2%)                                
      Pericardium, Inflammation, Suppurative                                     1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (50)         (50)         (50)                                   
      Accessory Adrenal Cortical Nodule                1 (2%)                    3 (6%)       3 (6%)                                
      Cytoplasmic Alteration, Focal                    3 (6%)       1 (2%)       1 (2%)                                             
      Hemorrhage                                       1 (2%)                    1 (2%)       1 (2%)                                
      Hyperplasia, Focal                               1 (2%)                                                                       
      Infiltration Cellular, Focal, Mixed Cell                                                1 (2%)                                
      Necrosis, Focal                                  1 (2%)                                                                       
   Adrenal Medulla                                    (50)         (49)         (50)         (50)                                   
      Angiectasis                                                                1 (2%)                                             
      Hyperplasia                                      5 (10%)      9 (18%)      8 (16%)      4 (8%)                                
   Islets, Pancreatic                                 (50)         (50)         (50)         (50)                                   
      Hyperplasia                                      1 (2%)                                                                       
   Pituitary Gland                                    (50)         (49)         (50)         (48)                                   
      Angiectasis                                      2 (4%)       3 (6%)       1 (2%)       1 (2%)                                
      Pars Distalis, Angiectasis                                                 1 (2%)                                             
      Pars Distalis, Cyst                              2 (4%)       4 (8%)       3 (6%)       2 (4%)                                
      Pars Distalis, Cytoplasmic Alteration, Focal     2 (4%)       3 (6%)       2 (4%)       2 (4%)                                
      Pars Distalis, Degeneration, Focal                                         1 (2%)                                             
      Pars Distalis, Hyperplasia, Focal                4 (8%)       3 (6%)       1 (2%)       3 (6%)                                
   Thyroid Gland                                      (50)         (50)         (50)         (50)                                   
      C-Cell, Hyperplasia                              6 (12%)      5 (10%)      5 (10%)      2 (4%)                                
      Follicle, Cyst                                   2 (4%)       4 (8%)       2 (4%)       2 (4%)                                
      Follicle, Pigmentation, Focal                                 1 (2%)       1 (2%)                                             
      Follicular Cell, Hyperplasia                                               5 (10%)                                            
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    9                                                              
NTP Experiment-Test: 05067-09         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            THEOPHYLLINE                                       Date: 07/11/96  
Route: GAVAGE                                                                                                     Time: 16:17:04  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     VEHICLE      7.5          25 MG/KG     75 MG/KG                                  
                                                   CONTROL      MG/KG                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (50)         (50)         (50)         (50)                                   
      Granuloma Sperm                                  1 (2%)                                                                       
      Inflammation, Chronic                                         3 (6%)                    1 (2%)                                
   Preputial Gland                                    (50)         (49)         (50)         (50)                                   
      Cyst                                             1 (2%)                                                                       
      Degeneration, Cystic                            10 (20%)      7 (14%)     10 (20%)      4 (8%)                                
      Hyperplasia                                                   3 (6%)                    4 (8%)                                
      Inflammation, Chronic                            5 (10%)      5 (10%)      8 (16%)      3 (6%)                                
   Prostate                                           (50)         (50)         (50)         (50)                                   
      Cyst                                             1 (2%)                                                                       
      Inflammation, Chronic                           30 (60%)     33 (66%)     31 (62%)     20 (40%)                               
      Epithelium, Hyperplasia, Focal                                             5 (10%)      2 (4%)                                
   Seminal Vesicle                                    (50)         (50)         (50)         (50)                                   
      Inflammation, Chronic                            1 (2%)                                                                       
   Testes                                             (50)         (50)         (50)         (50)                                   
      Cyst                                                          1 (2%)                                                          
      Germinal Epithelium, Degeneration                2 (4%)       4 (8%)       1 (2%)                                             
      Interstitial Cell, Hyperplasia                   2 (4%)       1 (2%)                    1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (50)         (50)         (50)                                   
      Myelofibrosis                                    2 (4%)                                                                       
      Necrosis, Focal                                               1 (2%)                                                          
   Lymph Node                                         (13)         (11)         (12)         (9)                                    
      Deep Cervical, Hyperplasia                                                              1 (11%)                               
      Iliac, Ectasia                                                1 (9%)                                                          
      Iliac, Hyperplasia                                                         1 (8%)                                             
      Inguinal, Hyperplasia                                         1 (9%)       1 (8%)                                             
      Inguinal, Hyperplasia, Lymphoid                                                         1 (11%)                               
      Inguinal, Pigmentation                                        1 (9%)                                                          
      Mediastinal, Ectasia                                          1 (9%)                                                          
      Mediastinal, Hemorrhage                          3 (23%)      3 (27%)      5 (42%)      5 (56%)                               
      Mediastinal, Hyperplasia, Lymphoid               1 (8%)                    1 (8%)                                             
      Mediastinal, Pigmentation                        4 (31%)      3 (27%)      2 (17%)      2 (22%)                               
      Pancreatic, Ectasia                                                        1 (8%)                                             
      Pancreatic, Hyperplasia, Histiocytic             1 (8%)                                                                       
      Pancreatic, Pigmentation                                                   1 (8%)                                             
   Lymph Node, Mandibular                             (48)         (49)         (50)         (50)                                   
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   10                                                              
NTP Experiment-Test: 05067-09         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            THEOPHYLLINE                                       Date: 07/11/96  
Route: GAVAGE                                                                                                     Time: 16:17:04  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     VEHICLE      7.5          25 MG/KG     75 MG/KG                                  
                                                   CONTROL      MG/KG                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Congestion                                                                              1 (2%)                                
      Ectasia                                                                    2 (4%)       1 (2%)                                
      Hemorrhage                                                    3 (6%)       6 (12%)      2 (4%)                                
      Hyperplasia                                                   1 (2%)       4 (8%)       1 (2%)                                
      Hyperplasia, Lymphoid                            1 (2%)                                                                       
   Lymph Node, Mesenteric                             (50)         (49)         (50)         (49)                                   
      Hyperplasia                                                                1 (2%)                                             
      Pigmentation                                     1 (2%)                                                                       
   Spleen                                             (49)         (50)         (50)         (49)                                   
      Fibrosis, Focal                                  4 (8%)       2 (4%)       2 (4%)                                             
      Hematopoietic Cell Proliferation                 4 (8%)       1 (2%)       2 (4%)                                             
      Hemorrhage                                       1 (2%)                                                                       
      Necrosis, Focal                                               1 (2%)                                                          
   Thymus                                             (49)         (47)         (47)         (50)                                   
      Angiectasis                                                                1 (2%)       3 (6%)                                
      Cyst                                                                                    2 (4%)                                
      Hemorrhage                                       1 (2%)       1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (48)         (49)         (47)         (48)                                   
      Cyst                                                                       1 (2%)       1 (2%)                                
      Ectasia                                         13 (27%)     10 (20%)      8 (17%)      6 (13%)                               
      Hyperplasia                                      1 (2%)       1 (2%)                    2 (4%)                                
      Inflammation, Chronic, Focal                                               1 (2%)                                             
   Skin                                               (50)         (50)         (50)         (50)                                   
      Cyst Epithelial Inclusion                                     1 (2%)                                                          
      Hyperkeratosis                                                                          1 (2%)                                
      Inflammation, Chronic, Focal                                                            2 (4%)                                
      Ulcer                                                                                   1 (2%)                                
      Dermis, Atrophy, Focal                                        1 (2%)                                                          
      Epidermis, Hyperplasia, Focal                                 1 (2%)       1 (2%)       2 (4%)                                
      Hair Follicle, Atrophy                                                     1 (2%)                                             
      Subcutaneous Tissue, Edema                       1 (2%)                                 2 (4%)                                
      Subcutaneous Tissue, Hemorrhage, Focal           2 (4%)                    1 (2%)       1 (2%)                                
      Subcutaneous Tissue, Inflammation, Chronic,                                                                                   
           Focal                                                                              4 (8%)                                
      Subcutaneous Tissue, Necrosis, Focal                                       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (50)         (50)                                   
      Callus                                                        1 (2%)                                                          
      Cranium, Hemorrhage                              1 (2%)                                                                       
   Skeletal Muscle                                    (4)          (1)          (1)                                                 
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   11                                                              
NTP Experiment-Test: 05067-09         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            THEOPHYLLINE                                       Date: 07/11/96  
Route: GAVAGE                                                                                                     Time: 16:17:04  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     VEHICLE      7.5          25 MG/KG     75 MG/KG                                  
                                                   CONTROL      MG/KG                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
MUSCULOSKELETAL SYSTEM - CONT                                                                                                       
      Hemorrhage, Focal                                1 (25%)      1 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (49)         (50)         (49)                                   
      Atrophy, Focal                                  10 (20%)     10 (20%)      8 (16%)      4 (8%)                                
      Hemorrhage, Focal                                3 (6%)                    3 (6%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (50)         (50)                                   
      Congestion                                       1 (2%)       1 (2%)                    8 (16%)                               
      Fibrosis, Focal                                               1 (2%)                                                          
      Foreign Body                                                               1 (2%)       2 (4%)                                
      Hemorrhage                                                                 2 (4%)       3 (6%)                                
      Hyperplasia, Histiocytic                                                                1 (2%)                                
      Inflammation, Chronic                                         1 (2%)       1 (2%)       2 (4%)                                
      Inflammation, Suppurative                        2 (4%)                                                                       
      Necrosis, Focal                                               1 (2%)                                                          
      Alveolar Epithelium, Hyperplasia                 7 (14%)      2 (4%)       2 (4%)       1 (2%)                                
      Interstitium, Edema                                                        1 (2%)                                             
      Mediastinum, Inflammation, Acute                                           1 (2%)                                             
      Serosa, Foreign Body                                                       1 (2%)       1 (2%)                                
      Serosa, Inflammation                                                       1 (2%)                                             
   Nose                                               (50)         (49)         (50)         (50)                                   
      Inflammation, Suppurative                        5 (10%)      3 (6%)       7 (14%)      3 (6%)                                
      Nasolacrimal Duct, Inflammation, Suppurative                  1 (2%)       1 (2%)                                             
      Respiratory Epithelium, Hyperplasia, Focal       1 (2%)       1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Ear                                                                                       (1)                                    
      External Ear, Inflammation, Chronic, Focal                                              1 (100%)                              
   Eye                                                (8)          (7)          (15)                                                
      Cataract                                         1 (13%)      1 (14%)                                                         
      Hemorrhage                                       2 (25%)                                                                      
      Retinal Detachment                               1 (13%)                                                                      
      Cornea, Pigmentation                             1 (13%)                                                                      
      Retina, Degeneration                                          1 (14%)                                                         
      Sclera, Metaplasia, Focal, Osseous               1 (13%)      2 (29%)      8 (53%)                                            
   Harderian Gland                                    (1)                                                                           
      Hypertrophy                                      1 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   12                                                              
NTP Experiment-Test: 05067-09         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            THEOPHYLLINE                                       Date: 07/11/96  
Route: GAVAGE                                                                                                     Time: 16:17:04  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     VEHICLE      7.5          25 MG/KG     75 MG/KG                                  
                                                   CONTROL      MG/KG                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (49)         (49)         (50)         (49)                                   
      Congestion                                       1 (2%)                                                                       
      Cyst                                             2 (4%)                    1 (2%)       1 (2%)                                
      Infarct                                                       1 (2%)                    1 (2%)                                
      Inflammation, Suppurative                                     1 (2%)                                                          
      Nephropathy                                     46 (94%)     44 (90%)     49 (98%)     48 (98%)                               
      Papilla, Mineralization, Focal                                1 (2%)                                                          
      Papilla, Necrosis                                             1 (2%)                                                          
      Renal Tubule, Accumulation, Hyaline Droplet      1 (2%)       1 (2%)                                                          
      Renal Tubule, Dilatation                                      2 (4%)                                                          
      Renal Tubule, Hyperplasia, Focal                                           1 (2%)                                             
      Renal Tubule, Pigmentation                                    1 (2%)       1 (2%)                                             
   Ureter                                                          (1)                                                              
      Inflammation, Chronic                                         1 (100%)                                                        
      Transitional Epithelium, Hyperplasia                          1 (100%)                                                        
   Urinary Bladder                                    (50)         (50)         (50)         (49)                                   
      Inflammation, Chronic                                         1 (2%)                                                          
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   13                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------